These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38306380)

  • 1. MALT Lymphoma in Histologic Transformation: FDG-Avid but Pentixafor-Negative.
    Tang R; Chen X; Liu M; Shu Q; Cai L
    Clin Nucl Med; 2024 Mar; 49(3):276-277. PubMed ID: 38306380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
    Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
    Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT Findings of MALT Lymphoma of Ureter.
    He L; Deng Y; Deng Y; Xie H; Zhang W
    Clin Nucl Med; 2022 Sep; 47(9):828-829. PubMed ID: 35930711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: A case series.
    Albano D; Bosio G; Orlando E; Bertagna F
    Hematol Oncol; 2017 Dec; 35(4):884-889. PubMed ID: 28004400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of baseline
    Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary mucosa-associated lymphoid tissue lymphoma:
    Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
    Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Albano D; Durmo R; Treglia G; Giubbini R; Bertagna F
    Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):137-146. PubMed ID: 32029397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
    Park SH; Lee JJ; Kim HO; Lee DY; Suh C; Jung HY; Choi KD; Kim DH; Huh J; Ryu JS
    Leuk Lymphoma; 2015; 56(12):3288-94. PubMed ID: 25804932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.
    Hoffmann M; Kletter K; Diemling M; Becherer A; Pfeffel F; Petkov V; Chott A; Raderer M
    Ann Oncol; 1999 Oct; 10(10):1185-9. PubMed ID: 10586335
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
    J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography integrated with computed tomography for accurate staging and surveillance in the case of mucosa-associated lymphoid tissue.
    Zhang S; Rossetti-Chung A; Sood S; Terezakis S
    J Radiol Case Rep; 2021 Mar; 15(3):19-28. PubMed ID: 34267867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue.
    Pang Y; Zhao L; Shang Q; Meng T; Chen H
    Clin Nucl Med; 2022 Apr; 47(4):375-377. PubMed ID: 34661557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.
    Treglia G; Zucca E; Sadeghi R; Cavalli F; Giovanella L; Ceriani L
    Hematol Oncol; 2015 Sep; 33(3):113-24. PubMed ID: 25047160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkitt Lymphoma/Leukemia Presented on 68Ga-Pentixafor and 18F-FDG PET/CT.
    Chen Z; Xue Q; Huang C; Yao S; Miao W
    Clin Nucl Med; 2022 Jan; 47(1):98-100. PubMed ID: 34115701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 PET/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line Helicobacter¬†pylori eradication.
    Mayerhoefer ME; Raderer M; Lamm W; Weber M; Kiesewetter B; Rohrbeck J; Simonitsch-Klupp I; Hacker M; Leisser A; Nics L; Schmitl S; Wester HJ; Haug A
    Blood; 2022 Jan; 139(2):240-244. PubMed ID: 34525196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
    Park YJ; Hyun SH; Moon SH; Lee KH; Min BH; Lee JH; Kim WS; Kim SJ; Choi JY
    Sci Rep; 2021 Apr; 11(1):9243. PubMed ID: 33927319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
    Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and review of the literature.
    Bao C; Wei J; Zhao X; Lin L; Chen D; Liu K; Qian W; Anas JM; Zhao K
    Medicine (Baltimore); 2018 Mar; 97(10):e9877. PubMed ID: 29517697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT and primary hepatic MALT: a case series.
    Albano D; Giubbini R; Bertagna F
    Abdom Radiol (NY); 2016 Oct; 41(10):1956-9. PubMed ID: 27259334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [
    Haug AR; Leisser A; Wadsak W; Mitterhauser M; Pfaff S; Kropf S; Wester HJ; Hacker M; Hartenbach M; Kiesewetter-Wiederkehr B; Raderer M; Mayerhoefer ME
    Theranostics; 2019; 9(12):3653-3658. PubMed ID: 31281504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.